Literature DB >> 26505894

The Role of Platelets and ε-Aminocaproic Acid in Arthrogryposis, Renal Dysfunction, and Cholestasis (ARC) Syndrome Associated Hemorrhage.

Angela C Weyand, Rebecca M Lombel, Steven W Pipe, Jordan A Shavit.   

Abstract

Arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome is a rare disorder associated with platelet abnormalities resembling gray platelet syndrome. Affected patients have normal platelet numbers but abnormal morphology and function. Bleeding symptomatology ranges from postprocedural to spontaneous life-threatening hemorrhage. We report a patient with ARC syndrome and compound heterozygous mutations in VPS33B (vacuolar protein sorting 33B) who presented with significant bleeding requiring numerous admissions and transfusions. She was treated with prophylactic platelet transfusions and ε-aminocaproic acid. This was well-tolerated and significantly decreased transfusion requirements and admissions for bleeding. Our experience provides support for consideration of prophylactic measures in these patients as well as the possibility of using prophylaxis in related disorders.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  ARC syndrome; epsilon aminocaproic acid; gray platelet syndrome; hemorrhage; platelet function disorder; platelets

Mesh:

Substances:

Year:  2015        PMID: 26505894      PMCID: PMC4724310          DOI: 10.1002/pbc.25814

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  18 in total

1.  A lethal familial syndrome associating arthrogryposis multiplex congenita, renal dysfunction, and a cholestatic and pigmentary liver disease.

Authors:  C Nezelof; M C Dupart; F Jaubert; E Eliachar
Journal:  J Pediatr       Date:  1979-02       Impact factor: 4.406

2.  VPS33B regulates protein sorting into and maturation of α-granule progenitor organelles in mouse megakaryocytes.

Authors:  Danai Bem; Holly Smith; Blerida Banushi; Jemima J Burden; Ian J White; Joanna Hanley; Nadia Jeremiah; Frédéric Rieux-Laucat; Ruth Bettels; Gema Ariceta; Andrew D Mumford; Steven G Thomas; Steve P Watson; Paul Gissen
Journal:  Blood       Date:  2015-05-06       Impact factor: 22.113

Review 3.  Clinical and pathological aspects of ARC (arthrogryposis, renal dysfunction and cholestasis) syndrome in two siblings.

Authors:  Neslihan Tekin; Sultan Durmuş-Aydoğdu; Ener Cağri Dinleyici; Ozcan Bör; Kismet Bildirici; Arif Akşit
Journal:  Turk J Pediatr       Date:  2005 Jan-Mar       Impact factor: 0.552

4.  Fanconi syndrome, ichthyosis, dysmorphism, jaundice and diarrhoea--a new syndrome.

Authors:  J E Deal; T M Barratt; M J Dillon
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

5.  ARC syndrome in preterm baby.

Authors:  A Elmeery; K Lanka; J Cummings
Journal:  J Perinatol       Date:  2013-10       Impact factor: 2.521

6.  Liver biopsy complicated by hemorrhage in a patient with ARC syndrome.

Authors:  Jason A Hayes; Walter H A Kahr; Bryan Lo; Bruce A Macpherson
Journal:  Paediatr Anaesth       Date:  2004-11       Impact factor: 2.556

7.  Requirement of VPS33B, a member of the Sec1/Munc18 protein family, in megakaryocyte and platelet alpha-granule biogenesis.

Authors:  Bryan Lo; Ling Li; Paul Gissen; Hilary Christensen; Patrick J McKiernan; Charles Ye; Mohamed Abdelhaleem; Jason A Hayes; Michael D Williams; David Chitayat; Walter H A Kahr
Journal:  Blood       Date:  2005-08-25       Impact factor: 22.113

8.  Cerebral defects and nephrogenic diabetes insipidus with the ARC syndrome: additional findings or a new syndrome (ARCC-NDI)?

Authors:  R A Coleman; J L Van Hove; C R Morris; J M Rhoads; M L Summar
Journal:  Am J Med Genet       Date:  1997-10-31

9.  Mutations in VPS33B, encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis-renal dysfunction-cholestasis (ARC) syndrome.

Authors:  Paul Gissen; Colin A Johnson; Neil V Morgan; Janneke M Stapelbroek; Tim Forshew; Wendy N Cooper; Patrick J McKiernan; Leo W J Klomp; Andrew A M Morris; James E Wraith; Patricia McClean; Sally A Lynch; Richard J Thompson; Bryan Lo; Oliver W Quarrell; Maja Di Rocco; Richard C Trembath; Hanna Mandel; S Wali; Fiona E Karet; A S Knisely; Roderick H J Houwen; Deirdre A Kelly; Eamonn R Maher
Journal:  Nat Genet       Date:  2004-03-28       Impact factor: 38.330

Review 10.  Arthrogryposis, renal dysfunction and cholestasis syndrome: report of five patients from three Italian families.

Authors:  M Di Rocco; F Callea; B Pollice; M Faraci; F Campiani; C Borrone
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

View more
  4 in total

1.  An uncommon case of arthrogryposis, renal dysfunction, and cholestasis (ARC) syndrome and review of the renal involvement: Answers.

Authors:  Minh Dien Duong; Chelsi M Rose; Kimberly J Reidy; Marcela Del Rio
Journal:  Pediatr Nephrol       Date:  2019-08-28       Impact factor: 3.714

2.  An eQTL Landscape of Kidney Tissue in Human Nephrotic Syndrome.

Authors:  Christopher E Gillies; Rosemary Putler; Rajasree Menon; Edgar Otto; Kalyn Yasutake; Viji Nair; Paul Hoover; David Lieb; Shuqiang Li; Sean Eddy; Damian Fermin; Michelle T McNulty; Nir Hacohen; Krzysztof Kiryluk; Matthias Kretzler; Xiaoquan Wen; Matthew G Sampson
Journal:  Am J Hum Genet       Date:  2018-07-26       Impact factor: 11.025

3.  A novel mutation in VPS33B gene causing a milder ARC syndrome phenotype with prolonged survival.

Authors:  Rodrigo Del Brío Castillo; James E Squires; Patrick J McKiernan
Journal:  JIMD Rep       Date:  2019-03-22

4.  VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.

Authors:  Yingxia Ning; Zhaoyang Zeng; Yuao Deng; Weifeng Feng; Lun Huang; Huiling Liu; Jiazhi Lin; Chen Zhang; Yue Fan; Longyang Liu
Journal:  Cancer Sci       Date:  2021-03-31       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.